Showing results (1651-1660 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|August 18, 2000
Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen)P Berto, P Tinuper, S ViaggiPharmacoeconomics|August 18, 2000
ACE inhibitors after myocardial infarction. Clinical and economic considerationsA P DaviePharmacoeconomics|August 18, 2000
Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndromeE L Eisenstein, E D Peterson, J G Jollis, et al.Pharmacoeconomics|August 18, 2000
Household income losses associated with ischaemic heart disease for US employeesJ Herrin, C B Cangialose, S J Boccuzzi, et al.Pharmacoeconomics|August 18, 2000
New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefitsG M HigaPharmacoeconomics|August 18, 2000
Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza. Zanamivir Study GroupF Y Aoki, D M Fleming, A D Griffin, et al.Pharmacoeconomics|August 18, 2000
Economic burden of irritable bowel syndrome. Proposed strategies to control expendituresM Camilleri, D E WilliamsPharmacoeconomics|June 1, 2001
Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literatureA M Rentz, C Battista, E Trudeau, et al.Pharmacoeconomics|January 31, 2002
Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision makingC Daniel Mullins, Junling WangPharmacoeconomics|January 5, 2002
Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDSJ H Kempen, K D Frick, D A JabsPageof 336